RALF KURIYEL
CIK 1733143 · Senior VP, R&D · last filed 2026-03-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.62M
Companies
1
Total Filings
44
Lifetime Open-Market Net
-$10.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGEN | Senior VP, R&D | 20,062 | $130.59 | $2.62M | -$10.63M | 44 | 2026-03-23 |
Recent Filings · Page 4 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-18 | RGEN | Sell (S) | −435 | -$81.0K | EDGAR |
| 2020-08-10 | RGEN | Mixed | — | -$599.6K | EDGAR |
| 2020-05-19 | RGEN | Sell (S) | −435 | -$61.2K | EDGAR |
| 2020-05-15 | RGEN | Mixed | — | -$756.3K | EDGAR |
| 2020-03-05 | RGEN | Sell (S) | −3,005 | -$271.6K | EDGAR |
| 2020-03-02 | RGEN | Grant (A) | +3,216 | $0 | EDGAR |
| 2020-02-27 | RGEN | Sell (S) | −195 | -$16.9K | EDGAR |
| 2019-12-18 | RGEN | Tax (F) | −295 | -$26.7K | EDGAR |
| 2019-06-11 | RGEN | Grant (A) | — | $0 | EDGAR |
| 2019-05-15 | RGEN | Grant (A) | +8,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.